Position in CRIS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$262,231
+$122,397 QoQ
Shares Held
25,215
+98.4% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 36 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRIS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. CRIS ranks #310 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in CRIS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $262,231 | 504,292 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $139,834 | 254,245 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $56 | 57 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,402 | 845 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,960 | 845 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,773 | 845 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,606 | 852 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $4,650 | 863 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $6,133 | 889 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $9,662 | 889 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $11,398 | 894 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $5,890 | 894 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $27,099 | 32,650 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $19,350 | 32,467 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $126,537 | 230,066 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $167,308 | 238,376 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $158,545 | 151,083 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $5,423,807 | 2,276,466 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,509,997 | 316,069 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,956,192 | 377,412 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,810,000 | 224,326 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $126,000 | 11,125 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $178,000 | 21,733 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $25,000 | 21,703 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $26,000 | 21,836 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $16,000 | 22,507 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||